Published in TB and Outbreaks Week, April 17th, 2001
The limited supply of alternative anti-malarials highlights a need for development of more effective and plentiful drugs in African nations, said Fred Nuwaha at Mbarara University in Uganda.
"There is emerging evidence that chloroquine-resistant P. falciparum (CRPF) is linked with increased incidence of mortality, severe disease and emergence of epidemics," Nuwaha said. "Whereas the normal response to this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.